Skip to main content

CRI Speaks

Let's spread the word about Immunotherapy! Click to share this page with your community.

Upcoming CRI Speaks

Currently there are no upcoming events.

Past CRI Speaks

March 03, 201912:00 PM
CRI Speaks

Inaugural Festival of Biologics San Diego

CEO Jill O’Donnell-Tormey, Ph.D., will be participating in the Women in Science panel on March 3, 2019 at 2:30 p.m. 

June 01, 20181:00 PM
CRI Speaks

2018 ASCO Meeting

CRI scientists are presenting at the Annual Meeting of the American Society of Clinical Oncologists. CRI is providing a daily recap of new work coming out of the conference. 

April 14, 20188:00 AM
CRI Speaks

2018 AACR Annual Meeting

Many CRI-funded and -affiliated scientists and clinicians will be showcased at the American Association of Cancer Research Annual Meeting on April 14-18, 2018, in Chicago, Illinois. 

April 12, 20187:15 AM
CRI Speaks

Cancer Advance Boston

On April 12, our chief medical officer, Aiman Shalabi, will be a featured expert on the panel, “Immuno-Oncology: Challenges & Opportunities”.

March 19, 20187:00 AM
CRI Speaks

Fortune Brainstorm HEALTH 2018

Dr. Jill O’Donnell-Tormey, CEO and director of scientific affairs, will participate in the 'Weaponizing Your Own Body' panel on Tuesday, March 20, 2018 at 7:45 am.

January 22, 20184:30 PM
CRI Speaks

Immuno-Oncology Frontiers World

Dr. Vanessa Lucey, associate director, CRI Venture Fund & Clinical Accelerator, is speaking during the "Back to Basics" session on January 23, 2018 at 2:00 p.m. 

January 09, 20187:00 AM
CRI Speaks

ENDPOINTS Executive Breakfast

Aiman Shalabi, Chief Medical Officer, is a panelist at the ENDPOINTS Executive Breakfast in San Francisco. This year's topic: “Where is the cancer R&D revolution headed?”

January 08, 20187:00 AM
CRI Speaks

Biotech Showcase

CRI's CEO and Director of Scientific Affairs, Dr. Jill O’Donnell-Tormey, is a panelist on “IO on the move: New targets, new trends, new combinations” on January 10, 2018.

December 07, 201712:00 PM
CRI Speaks

ESMO Immuno Oncology Congress 2017

CRI's CMO Aiman Shalabi, Pharm.D., MBA, BCOP, is speaking at the pre-conference press conference and presenting in the session "The role of philanthropy in supporting cancer immunotherapy." 

October 05, 201712:30 PM
CRI Speaks

XVth NIBIT Meeting

Aiman Shalabi, Pharm.D., MBA, BCOP, chief medical officer of the Cancer Research Institute, presents on Saturday, October 7, 2017 in the "Prospective NIBIT and NIBIT Foundation collaborations" session. 

*Immunotherapy results may vary from patient to patient.

Top